⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8714815 | 0.73 | — | — | |
| SCHEMBL13427496 | 0.69 | — | — | |
| SCHEMBL159365 | 0.67 | — | — | |
| SCHEMBL131834 | 0.65 | — | — | |
| SCHEMBL1932218 | 0.65 | — | — | |
| SCHEMBL12553070 | 0.65 | — | — | |
| SCHEMBL9219270 | 0.65 | — | — | |
| SCHEMBL4315466 | 0.62 | — | — | |
| SCHEMBL8032217 | 0.62 | — | — | |
| Acetone SCHEMBL3466447 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101568534-A | Benzoylamino heterocyclic compounds for the treatment of GLK mediated diseases | ASTRAZENECA AB (SE) | 2009-10-28 | — | — | CN | disclosed |